Faculty of Medicine

Prof.Dr. Manal Anwar EL-Hawary

Contact Information
Phone Number: 084 6300587                          
Fax Number: 084 6302350
E-mail Address: mae04@fayoum.edu.eg
Office: Bulding Of Faculty Medicine - Pediatrics Department
Post Address: Fayoum University - Faculty of Medicine - Pediatrics Department - POBox: 63514

Academic Qualifications

B. Sc.: Medicine and Surgery - Faculty of Medicine - Cairo University - 1988
M. Sc.: Pediatrics - Faculty of Medicine - Cairo University - 1992
Ph. D.: Pediatrics - Faculty of Medicine - Cairo University - 1999

Academic Positions

Assistant Lecturer : from 1992 To 1999
Lecturer : from 1999 To 2005
Assistant Professor : From 2005 To 2015
Professor : From 2015 Until Now

Research Interests

Pediatric Hepatology.
Neonatal Jaundice.

Thesis

Recent Trends In Cystic Fibrosis .
Portal Vein Obstruction Following Exchange Transfusion A Prospective Study Using Ultrasound .

Publication List Interests

Safety and Efficacy of Hepatitis A Vaccine in Children with Chronic Liver Disease. .
Prevalence and Risk Factors of Asymptomatic Hepatitis C Virus Infection in Egyptian Children. .
Assessment of Hepatic Fibrosis in Pediatric Cases with Hepatitis C Virus in Egypt. .
Clinical Practice. NTBC Therapy for Tyrosinemia Type 1: How Much Is Enough? .
Anti-HCV Prevalence among Diabetic and Non-Diabetic Egyptian Children. .
Can aspartate aminotransferase to platelet ratio index replace liver biopsy in chronic hepatitis C? .
Patterns of Hepatitis B Virus Infection in Egyptian Children in The Era of Obligatory Hepatitis B Vaccination. .
Assessment of Coagulation and Fibrinolysis in Children with Chronic Liver Disease. .
Adipokines in Chronic Liver Diseases; Role in Pediatric Patients .
A clinical study of Wilson’s disease: The experience of a single Egyptian Paediatric Hepatology Unit.
Outcome of Extrahepatic Portal Vein Obstruction in Children.
Methylenetetrahydrofolate reductase C677T gene mutation prevalence and its contribution with other thrombophilic factors in pediatric cases with portal vein thrombosis .